Delivery Order SPE2DE24D0021-SPE2D625F3HLP
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,100 delivery order to Fisher Scientific Company L.L.C. on September 11, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunoassay products. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of November 7, 2025, and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania facility. The award utilized no set-aside designation and represents a competitive procurement to...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $2,764.60 by the Defense Medical Supply Chain for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The delivery order, issued on August 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 6, 2025. The work will be performed in Pittsburgh, Pennsylvania. This award represents a child...
- Fisher Scientific Company L.L.C. was awarded a $4,400 fixed-price delivery order with economic price adjustment authority for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies on September 4, 2025. The contract, which carries no set-aside designation, is a child award under a larger vehicle and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of October 31, 2025. The funding agency is the Department of Defense Medical...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 for SOFIA 2 Flu + SARS antigen fluorescent diagnostic supplies by the Medical Supply Chain, a defense-focused federal agency, with an award date of September 4, 2025 and ultimate completion by October 31, 2025. The contract employs fixed-price pricing with economic price adjustment and carries no set-aside designation, reflecting open competition procurement. Performance will take place at Fisher Scientific's...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1.65K to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by October 22, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle structure, with no small...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300.00 on August 18, 2025, for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 15, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract is funded through the Medical Supply Chain, a defense-oriented federal agency, and is structured as a child contract under a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,423.36 on July 31, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price delivery order with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is scheduled for completion by September 26, 2025. The contract was awarded without a set-aside designation through open competition to the Medical Supply Chain, a defense-focused federal agency. As a...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3HLPDelivery Order
Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $6,600.00 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies under a fixed-price contract with economic price adjustment provisions. The contract, awarded on September 12, 2025, with an ultimate completion date of November 10, 2025, will be performed in Pittsburgh, Pennsylvania. The awardee is a major supplier of laboratory supplies, scientific instruments, and medical equipment to federal agencies, registered in SAM.gov since July 2001. This delivery order is being funded by the Medical Supply Chain office within the Department of Defense and represents an open competition award with no set-aside designation. The delivery order supports diagnostic testing capabilities, likely for military or defense-related medical supply operations. Fisher Scientific has demonstrated extensive capabilities in delivering specialized laboratory and medical equipment across multiple federal agencies, including the National Institutes of Health, Department of Veterans Affairs, Department of Agriculture, and the Food and Drug Administration. The company's recent contract history reflects consistent success in competitive federal procurements, and it holds a significant Blanket Purchase Agreement with the Department of Veterans Affairs valued at $1.65 million for toxicology and drugs of abuse reagents, indicating its established role as a critical vendor for federal healthcare and testing initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 9/12/25 |